APRIL JONES: Open Payments
NPI 1972049997 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 28 payments from 15 companies in 2025. Trend: 2023 $709 · 2024 $691 · 2025 $918
Food & beverage: $849Education: $69
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $167 |
| Phathom Pharmaceuticals, Inc. | 3 | $153 |
| Novo Nordisk Inc | 1 | $122 |
| ABBVIE INC. | 5 | $114 |
| Astellas Pharma US Inc | 2 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| ViiV Healthcare Company | 2 | $46 |
| Seqirus USA Inc | 1 | $21 |
| Acera Surgical, Inc. | 1 | $19 |
Products named: VOQUEZNA, Ozempic, CAPLYTA, VRAYLAR, BREZTRI, APRETUDE, UBRELVY, AREXVY.
Industry payments across UT — which companies pay providers there.
